Skip to content
NNIT SafeCoder

News -

NNIT SafeCoder

To prevent counterfeit and its lethal and financial impact, regulation requiring serialization is enforced. But even serial numbers can be counterfeited, especially if batches have sequential codes. Enter the need to generate unique bar codes and serial numbers that are not computed algorithmically. Such capability also needs to operate globally to ensure compliance around the world. NNIT’s SafeCoder™ does exactly this.

As the pharmaceutical industry has grown in complexity, so too has its supply chain. There are more products, devices and ingredients, and this has led to the expansion of intermediaries. There is, therefore, a heightened risk for a counterfeit product or ingredient to slip in unnoticed at some point between the producer and the patient.

Read the article here

Topics

Contacts

Tina Joanne Hindsbo

Tina Joanne Hindsbo

Press contact Head of Public & Media Relations +45 3077 9578
Sofie Mand Steffens

Sofie Mand Steffens

Press contact Senior Communications Consultant +45 3077 8337

Related content

Your Licence to Sell is at Stake

Your Licence to Sell is at Stake

With an approaching serialisation deadline, following the introduction of new legislation in the pharmaceuticals market to deal with the threat of counterfeit drugs, Clinical Trials Insight talks to Lars Højberg, life sciences expert at NNIT, about the best strategy for complying with serialisation.
Read the article here

Make the most of serialization

Change is afoot for pharmaceutical companies, with new serialisation legislation on the agenda. To help stem the problem of drug counterfeiting, they will be required to adopt a unique serial number labelling system and adapt their business processes accordingly. How can companies derive real business value from the investments they are now required to make?